Marketing-authorisation holder · Ireland

Amdipharm Limited

Ireland79 medicines6 countries

79 medicines in 6 countries, as authorisation holder and manufacturer.

Medicines

Every medicine in the registers under its name, current ones first.

1–25 of 79

Medicine	Substance	Country	Status	Authorised
ANDROCUR50 mg · Tablet	Cyproterone	Canada	Marketed	1987
CAFERGOT 1 mg/100 mg COMPRIMIDOS100 mg + 1 mg · Comprimido	Caffeine, Ergotamine	Spain	Marketed	1954
Diamox 250 mg tabletetableta	Acetazolamide	Croatia	Marketed	2020
Diamox parenteraal 500 mg, poeder voor injectievloeistofPoeder voor oplossing voor injectie	Acetazolamide	Netherlands	Authorised	1967
Diamox, tabletten 250 mgTablet	Acetazolamide	Netherlands	Authorised	1967
ERYTHROCIN I.V.1 g / vial · Powder For Solution	Erythromycin	Canada	Marketed	1988
ERYTHROCIN I.V.500 mg / vial · Powder For Solution	Erythromycin	Canada	Marketed	1988
Erythrocine 250 mg tablettenOmhulde tablet	Erythromycin	Netherlands	Authorised	1967
Erythrocine ES 125 mg/5 ml, granulaat voor orale suspensieGranulaat voor orale suspensie	Erythromycin	Netherlands	Authorised	1985
Erythrocine ES 250 mg/5 ml, granulaat voor orale suspensieGranulaat voor orale suspensie	Erythromycin	Netherlands	Authorised	1985
Erythrocine I.V., poeder voor oplossing voor infusie 1 gPoeder voor oplossing voor infusie	Erythromycin	Netherlands	Authorised	1967
FUCITHALMIC1 % / w/w · Drops	Fusidic acid	Canada	Marketed	2001
FUCITHALMIC 10 mg/g GEL OFTALMICO10 mg · Gel oftálmico	Fusidic acid	Spain	Marketed	1990
Fucithalmic 10 mg/g ooggelOoggel	Fusidic acid	Netherlands	Authorised	1988
Furabid, capsules met gereguleerde afgifte 100 mgCapsule met gereguleerde afgifte, hard	Nitrofurantoin	Netherlands	Authorised	1994
Furadantine MC 50 mg, capsulesCapsule, hard	Nitrofurantoin	Netherlands	Authorised	1969
HIGROTONA 50 mg comprimidos50 mg · Comprimido	Chlorthalidone	Spain	Marketed	1968
Hytrin 10, tabletten 10 mgTablet	Terazosin	Netherlands	Authorised	1991
Hytrin 2, tabletten 2 mgTablet	Terazosin	Netherlands	Authorised	1991
Hytrin 5, tabletten 5 mgTablet	Terazosin	Netherlands	Authorised	1991
Locacorten, creme 0,02%Crème	Flumetasone	Netherlands	Authorised	1965
Locacorten-Vioform, cremeCrème	Clioquinol, Flumetasone	Netherlands	Authorised	1966
Locacorten-Vioform, oordruppelsOordruppels, oplossing	Clioquinol, Flumetasone	Netherlands	Authorised	1968
Locasalen, zalfZalf	Flumetasone, Salicylzuur	Netherlands	Authorised	1970
MYRELEZ 120 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG133,33 mg · Solución inyectable en jeringa precargada	Lanreotide	Spain	Marketed	2021

Sources and licences

Country	Medicines	Current	Past	Companies
Netherlands	31	31	0	Companies All medicines
Spain	30	22	8	Companies All medicines
Canada	15	7	8	Companies All medicines
European Union (EMA)	1	1	0	Companies All medicines
Croatia	1	1	0	Companies All medicines
Saudi Arabia	1	1	0	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

INVIMA

Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.

Licence: CC BY-SA 4.0

All 21 sources

Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA)

Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.

Licence: CC BY-SA 4.0

Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), Germany

Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), published shortage reports CSV, retrieved 2026-10-28.

Licence: commercial redistribution permission not established

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

BDPM / ANSM, HAS and UNCAM, France

BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

HALMED — Agencija za lijekove i medicinske proizvode RH

HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.

Licence: Otvorena dozvola RH

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Saudi Food and Drug Authority

Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.

Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only

Läkemedelsverket, Sweden

Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

Läkemedelsverket, Sweden

Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

Report an error or request removal Corrections from the company itself are welcome.

Amdipharm Limited

Medicines

Know your medicines, with the sources.

Amdipharm Limited

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Work with Prognia

Ireland: more companies